Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Nephroplus

    Jump to

    • Nephrocare Health Services IPO subscribed 36% on day 2; check GMP

      The company has fixed a price band of Rs 438-460 per share for its upcoming IPO, valuing the company at over Rs 4,600 crore

    • NephroPlus IPO: Is this single-speciality healthcare player worth a look?

      India’s largest dialysis service provider and the only domestic player has scaled up internationally

    • Dialysis chain NephroPlus to file papers for Rs 2,000-crore IPO this month

      The proceeds from the first mainboard IPO in India’s fast-growing dialysis sector will be used to scale operations, including acquisitions of mid-sized firms in India and the Philippines

    • Investcorp closes Rs 316cr investment in NephroPlus

    • NephroPlus to raise Rs 150 crore for international expansion

    • NephroPlus to open up to 55 dialysis centres by 2018-end

    • NephroPlus raises Rs 100 cr in funding for expansion

    • 'It is wise to let your bosses know about your dream'

      Kamal Shah, Co-founder Nephroplus, a chain of kidney-care centres across India

    • NephroPlus: Treating renal disorders innovatively

      NephroPlus, a kidney-care clinic chain has been built to cater to the demand for world-class specialised dialysis services across India‘s metros, is tackling this problem in an innovative way.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347